CD24 and neoplasm: Tumors with high percentage of BCSCs generally have a worse prognosis (Kristiansen et al., 2003) since as few as 1 × 103 BCSCs can regenerate an entire tumor including both CD24− and CD24+ cells (Yan et al., 2013).